Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association between serum NPTX2 and cognitive function in patients with vascular dementia
Keke Shao, Shiqin Shan, Wenwen Ru, et al.
Brain and Behavior (2020) Vol. 10, Iss. 10
Open Access | Times Cited: 25

Showing 25 citing articles:

NPTX2 in Cerebrospinal Fluid Predicts the Progression From Normal Cognition to Mild Cognitive Impairment
Anja Soldan, Sungtaek Oh, Taekyung Ryu, et al.
Annals of Neurology (2023) Vol. 94, Iss. 4, pp. 620-631
Open Access | Times Cited: 23
Fluid biomarkers of the neurovascular unit in cerebrovascular disease and vascular cognitive disorders: A systematic review and meta-analysis
Gurpreet Kaur Hansra, Tharusha Jayasena, Satoshi Hosoki, et al.
Cerebral Circulation - Cognition and Behavior (2024) Vol. 6, pp. 100216-100216
Open Access | Times Cited: 14
Exploring the Relationship Between Serum Neuronal Pentraxin 2 and Poststroke Cognitive Impairment in Patients With First‐Episode Acute Ischemic Stroke
Jie Li, Wenyang Ma, Shiyuan Gu
Brain and Behavior (2025) Vol. 15, Iss. 2
Open Access | Times Cited: 1
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia
Emma L. van der Ende, Esther E. Bron, Jackie M. Poos, et al.
Brain (2021) Vol. 145, Iss. 5, pp. 1805-1817
Open Access | Times Cited: 42
A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias
Katharina Bolsewig, Yanaika S. Hok‐A‐Hin, Federica Nicoletta Sepe, et al.
Journal of Alzheimer s Disease (2022) Vol. 90, Iss. 1, pp. 363-380
Open Access | Times Cited: 24
Blood Biomarkers for Alzheimer’s Disease in Down Syndrome
Laia Montoliu‐Gaya, André Strydom, Kaj Blennow, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 16, pp. 3639-3639
Open Access | Times Cited: 31
Circulating biomarkers of inflammaging and Alzheimer’s disease to track age-related trajectories of dementia: Can we develop a clinically relevant composite combination?
Angela Marie Abbatecola, Angelica Giuliani, Leonardo Biscetti, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102257-102257
Closed Access | Times Cited: 4
General and specific patterns of cortical gene expression as spatial correlates of complex cognitive functioning
Joanna E. Moodie, Sarah E. Harris, Mathew A. Harris, et al.
Human Brain Mapping (2024) Vol. 45, Iss. 4
Open Access | Times Cited: 4
Blood biomarkers for vascular cognitive impairment based on neuronal function: a systematic review and meta-analysis
Weiquan Huang, Libin Liao, Q. Liu, et al.
Frontiers in Neurology (2025) Vol. 16
Open Access
Promoter Hypomethylation of TGFBR3 as a Risk Factor of Alzheimer’s Disease: An Integrated Epigenomic-Transcriptomic Analysis
Hui Song, Jue Yang, Wenfeng Yu
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 18
Elevated Levels of Serum Neurofilament Light Chain Associated with Cognitive Impairment in Vascular Dementia
Weibin Ma, Jingjing Zhang, Jialei Xu, et al.
Disease Markers (2020) Vol. 2020, pp. 1-5
Open Access | Times Cited: 18
miR‐221 and Parkinson's disease: A biomarker with therapeutic potential
Mohammad Yasin Zamanian, Mehraveh Sadeghi Ivraghi, Reena Gupta, et al.
European Journal of Neuroscience (2023) Vol. 59, Iss. 2, pp. 283-297
Open Access | Times Cited: 6
CSF-Targeted Proteomics Indicate Amyloid-Beta Ratios in Patients with Alzheimer’s Dementia Spectrum
Maryam Behzad, Negin Zirak, Ghazal Hamidi Madani, et al.
International Journal of Alzheimer s Disease (2023) Vol. 2023, pp. 1-9
Open Access | Times Cited: 5
Association of reduced cerebrospinal fluid NPTX2 levels with postoperative delirium in patients undergoing knee/hip replacement: a prospective cohort study
Zongxiao Guo, Xiaoli Hong, Xiang Wang, et al.
Aging Clinical and Experimental Research (2024) Vol. 36, Iss. 1
Open Access | Times Cited: 1
Increased Levels of Serum Neuregulin 1 Associated with Cognitive Impairment in Vascular Dementia
Xiaoling Wang, Fengyu Zhang, Weibin Ma, et al.
BioMed Research International (2020) Vol. 2020, pp. 1-5
Open Access | Times Cited: 8
Alzheimer diseases
Alena Savonenko, Philip C. Wong, Tong Li
Elsevier eBooks (2022), pp. 313-336
Open Access | Times Cited: 5
VAMP-2 is a surrogate cerebrospinal fluid marker of Alzheimer-related cognitive impairment in adults with Down syndrome
Alberto Lléo, María Carmona‐Iragui, Laura Videla, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Biofluid biomarkers for Alzheimer’s disease
Sensen Wang, S. Xie, Qinpin Zheng, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access
Serum NPTX2 as a Potential Predictive Biomarker for Postoperative Delirium in Patients with Acute Type A Aortic Dissection
Wenxue Liu, Y. Wang, Yi Jiang, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 979-987
Open Access
General and specific patterns of cortical gene expression as spatial correlates of complex cognitive functioning
Joanna E. Moodie, Sarah E. Harris, Mathew A. Harris, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Bioinformatics and next generation sequencing data analysis to identify key genes and pathways influencing in Parkinson’s disease
Basavaraj Vastrad, Chanabasayya Vastrad
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
COVID-19 and alcohol use disorder: putative differential gene expression patterns that might be associated with neurological complications
Jibran Sualeh Muhammad, Ruqaiyyah Siddiqui, Naveed Ahmed Khan
Hospital Practice (2022) Vol. 50, Iss. 3, pp. 189-195
Closed Access | Times Cited: 1
miR-221 and Parkinson’s disease: A biomarker with therapeutic potential
Mohammad Yasin Zamanian, Mehraveh Sadeghi Ivraghi, Reena Gupta, et al.
Authorea (Authorea) (2023)
Open Access
Serum neuronal pentraxin 2 is related to cognitive dysfunction and electroencephalogram slow wave/fast wave frequency ratio in epilepsy
Xiaofen Huang, Xu Mingxia, Yue-Fan Chen, et al.
World Journal of Psychiatry (2023) Vol. 13, Iss. 10, pp. 714-723
Open Access
VAMP-2 Is a Surrogate Cerebrospinal Fluid Marker of Alzheimer-related Cognitive Impairment in Adults With Down Syndrome
Alberto Lleó, María Carmona‐Iragui, Laura Videla, et al.
Research Square (Research Square) (2021)
Open Access
Page 1

Scroll to top